Terminology Service < Semantic Lookup Platform

All terms in HP

Label	Id	Description
1st arch maxillary component	UBERON_0007238
embryonic facial prominence	UBERON_0012314	[One of five swellings formed during the development of the face]
maxillary process ectoderm	UBERON_0012312
maxillary prominence	UBERON_0005868	[the paired dorsal prominences formed by bifurcation of the first pharyngeal arches in the embryo that unite with the ipsilateral medial nasal process to form the upper jaw]
Normochromic microcytic anemia	HP_0004856	[A type of anemia characterized by an normal concentration of hemoglobin in the erythrocytes and lower than normal size of the erythrocytes.]
Microcytic anemia	HP_0001935	[A kind of anemia in which the volume of the red blood cells is reduced.]
Hyperchromic macrocytic anemia	HP_0004857	[A type of anemia characterized by abnormally large erythrocytes with abnormally high amounts of haemoglobin.]
Macrocytic anemia	HP_0001972	[A type of anemia characterized by increased size of erythrocytes with increased mean corpuscular volume (MCV) and increased mean corpuscular hemoglobin (MCH).]
Intermittent thrombocytopenia	HP_0004854	[Reduced platelet count that occurs sporadically, i.e., it comes and goes.]
Thrombocytopenia	HP_0001873	[A reduction in the number of circulating thrombocytes.]
bilirubin(2-)	CHEBI_57977	[A dicarboxylic acid dianion obtained by deprotonation of the two carboxy groups of bilirubin; major species at pH 7.3.]
dicarboxylic acid dianion	CHEBI_28965	[A carboxylic acid dianion obtained by deprotonation of both carboxy groups of any dicarboxylic acid.]
linear tetrapyrrole anion	CHEBI_59252	[An organic anion arising from deprotonation of a acyclic tetrapyrrole compound.]
bilirubin IXalpha	CHEBI_16990	[A member of the class of biladienes that is a linear tetrapyrrole with the dipyrrole units being of both exovinyl and endovinyl type. A product of heme degradation, it is produced in the reticuloendothelial system by the reduction of biliverdin and transported to the liver as a complex with serum albumin.]
Reduced protein S activity	HP_0004855	[An abnormality of coagulation related to a decreased concentration of vitamin K-dependent protein S. Protein S is a cofactor of protein C.]
Abnormality of the protein C anticoagulant pathway	HP_0030780	[An anomaly of the protein C anticoagulant pathway, which serves as a major system for controlling thrombosis, limiting inflammatory responses, and potentially decreasing endothelial cell apoptosis in response to inflammatory cytokines and ischemia. A natural anticoagulant system denoted the protein C pathway exerts its anticoagulant effect by regulating the activity of FVIIIa and FVa. The vitamin K-dependent protein C is the key component of the pathway. Activated protein C (APC) cleaves and inhibits coagulation cofactors FVIIIa and FVa, which result in downregulation of the activity of the coagulation system. The endothelial protein C receptor stimulates the T-TM-mediated activation of protein C on the endothelial cell surface. The two cofactors, protein S and the intact form of FV, enhance the anticoagulant activity of APC.]
Reduced leukocyte alkaline phosphatase	HP_0004852	[A decreased alkaline phosphatase activity measured within leukocytes.]
Low alkaline phosphatase	HP_0003282	[Abnormally reduced serum levels of alkaline phosphatase activity.]
Recurrent deep vein thrombosis	HP_0004850	[Repeated episodes of the formation of a blot clot in a deep vein.]
Deep venous thrombosis	HP_0002625	[Formation of a blot clot in a deep vein. The clot often blocks blood flow, causing swelling and pain. The deep veins of the leg are most often affected.]